|
1
|
Smolle MA and Pichler M: The role of long
non-coding RNAs in osteosarcoma. Noncoding RNA. 4:72018.
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyers PA, Schwartz CL, Krailo M,
Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W,
Gebhardt M, Goorin AM, et al: Osteosarcoma: A randomized,
prospective trial of the addition of ifosfamide and/or muramyl
tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J
Clin Oncol. 23:2004–2011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bishop MW, Janeway KA and Gorlick R:
Future directions in the treatment of osteosarcoma. Curr Opin
Pediatr. 28:26–33. 2016. View Article : Google Scholar :
|
|
5
|
Biazzo A and De Paolis M:
Multidisciplinary approach to osteosarcoma. Acta Orthop Belg.
82:690–698. 2016.
|
|
6
|
Reed DR, Hayashi M, Wagner L, Binitie O,
Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein
SC and Isakoff MS: Treatment pathway of bone sarcoma in children,
adolescents, and young adults. Cancer. 123:2206–2218. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dean DC, Shen S, Hornicek FJ and Duan Z:
From genomics to metabolomics: Emerging metastatic biomarkers in
osteosarcoma. Cancer Metastasis Rev. 37:719–731. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo X, Wei Y, Wang Z, Liu W, Yang Y, Yu X
and He J: LncRNA LINC00163 upregulation suppresses lung cancer
development though transcriptionally increasing TCF21 expression.
Am J Cancer Res. 8:2494–2506. 2018.
|
|
11
|
Jing H, Xia H, Qian M and Lv X: Long
noncoding RNA CRNDE promotes non-small cell lung cancer progression
via sponging microRNA-338-3p. Biomed Pharmacother. 110:825–833.
2019. View Article : Google Scholar
|
|
12
|
Chen Z, Hu X, Wu Y, Cong L, He X, Lu J,
Feng J and Liu D: Long non-coding RNA XIST promotes the development
of esophageal cancer by sponging miR-494 to regulate CDK6
expression. Biomed Pharmacother. 109:2228–2236. 2019. View Article : Google Scholar
|
|
13
|
Bian Y, Gao G, Zhang Q, Qian H, Yu L, Yao
N, Qian J, Liu B and Qian X: KCNQ1OT1/miR-217/ZEB1 feedback loop
facili-tates cell migration and epithelial-mesenchymal transition
in colorectal cancer. Cancer Biol Ther. 20:886–896. 2019.
View Article : Google Scholar :
|
|
14
|
Dong Z, Yang P, Qiu X, Liang S, Guan B,
Yang H, Li F, Sun L, Liu H, Zou G and Zhao K: KCNQ1OT1 facilitates
progression of non-small-cell lung carcinoma via modulating
miRNA-27b-3p/HSP90AA1 axis. J Cell Physiol. 234:11304–11314. 2019.
View Article : Google Scholar
|
|
15
|
Li Y, Li C, Li D, Yang L, Jin J and Zhang
B: lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in
colon cancer by targeting the miR-34a/ATG4B pathway. Onco Targets
Ther. 12:2649–2660. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei R, Ding C, Rodriguez RA and Del Mar
Requena Mullor M: The SOX2OT/miR-194-5p axis regulates cell
proliferation and mobility of gastric cancer through suppressing
epithelial-mesenchymal transition. Oncol Lett. 16:6361–6368.
2018.PubMed/NCBI
|
|
17
|
Luo Y, Tan W, Jia W, Liu Z, Ye P, Fu Z, Lu
F, Xiang W, Tang L, Yao L, et al: The long non-coding RNA LINC01606
contributes to the metastasis and invasion of human gastric cancer
and is associated with Wnt/β-catenin signaling. Int J Biochem Cell
Biol. 103:125–134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Gao X, Ge J, Li W, Zhou W and Xu L: LncRNA
KCNQ1OT1 promotes osteogenic differentiation to relieve osteolysis
via Wnt/β-catenin activation. Cell Biosci. 8:192018. View Article : Google Scholar
|
|
20
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karreth FA and Pandolfi PP: ceRNA
cross-talk in cancer: When ce-bling rivalries go awry. Cancer
Discov. 3:1113–1121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Wang Y, Hu R, Xu R and Xu W: LncRNA
B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and
migration via enhancing YAP transcriptional activity. Cell Prolif.
51:e125042018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu R, Feng F, Yu X, Liu Z and Lao L:
LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and
predicts poor survival and recurrence in human osteosarcoma. Cell
Prolif. 51:e125152018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Srivastava SK, Bhardwaj A, Leavesley SJ,
Grizzle WE, Singh S and Singh AP: MicroRNAs as potential clinical
biomarkers: Emerging approaches for their detection. Biotech
Histochem. 88:373–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adams BD, Parsons C, Walker L, Zhang WC
and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest.
127:761–771. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang XZ, Cheng TT, He QJ, Lei ZY, Chi J,
Tang Z, Liao QX, Zhang H, Zeng LS and Cui SZ: LINC01133 as ceRNA
inhibits gastric cancer progression by sponging miR-106a-3p to
regulate APC expression and the Wnt/β-catenin pathway. Mol Cancer.
17:1262018. View Article : Google Scholar
|
|
28
|
Zhan Y, Chen Z, Li Y, He A, He S, Gong Y,
Li X and Zhou L: Long non-coding RNA DANCR promotes malignant
phenotypes of bladder cancer cells by modulating the miR-149/MSI2
axis as a ceRNA. J Exp Clin Cancer Res. 37:2732018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu B, Pan S, Xiao Y, Liu Q, Xu J and Jia
L: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer
progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
J Exp Clin Cancer Res. 37:3162018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fei D, Zhang X, Liu J, Tan L, Xing J, Zhao
D and Zhang Y: Long noncoding RNA FER1L4 suppresses tumorigenesis
by regulating the expression of PTEN targeting miR-18a-5p in
osteosarcoma. Cell Physiol Biochem. 51:1364–1375. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pan L, Tang Z, Pan L and Tang R:
MicroRNA-3666 inhibits lung cancer cell proliferation, migration,
and invasiveness by targeting BPTF. Biochem Cell Biol. 97:415–422.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi H, Ji Y, Zhang D, Liu Y and Fang P:
MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of
non-small cell lung cancer cells. Oncol Rep. 36:3051–3057. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao L, Zhang Y, Liu J, Yin W, Jin D, Wang
D and Zhang W: MiR-185 inhibits cell proliferation and invasion of
non-small cell lung cancer by targeting KLF7. Oncol Res.
27:1015–1023. 2019. View Article : Google Scholar
|
|
34
|
An YX, Shang YJ, Xu ZW, Zhang QC, Wang Z,
Xuan WX and Zhang XJ: STAT3-induced long noncoding RNA LINC00668
promotes migration and invasion of non-small cell lung cancer via
the miR-193a/KLF7 axis. Biomed Pharmacother. 116:1090232019.
View Article : Google Scholar : PubMed/NCBI
|
